Back

PKP2 gene therapy reduces ventricular arrhythmias, reverses ventricular remodeling, improves heart function, and reduces mortality in a mouse model of arrhythmogenic right ventricular cardiomyopathy

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Basic science 1 Cardiac Diseases EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Jane Yang

Tenaya Therapeutics, South San Francisco (United States of America)

8 More presentations in this session

Presentation thumbnail
Right ventricular pacing-evoked left ventricular dysfunction is exaggerated by sustained left ventricular pressure overload in a rat model
Doctor M. Ruppert (Boston, US)
Abstract Slides Video
Presentation thumbnail
Bioenergetics and mitochondrial deregulation underlie self-sustained persistency of atrial fibrillation in an ovine model
Doctor G. Caluori (Bordeaux, FR)
Abstract Slides Video
Presentation thumbnail
Senolysis ameliorates increased susceptibility to ventricular arrhythmias in prediabetes
Doctor S. Angendohr (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
The entrainment of action potential duration and contraction amplitude by recapitulation of respiratory sinus arrhythmia in isolated cardiac myocytes
Doctor A. Carpenter (Bristol, GB)
Abstract Slides Video
Presentation thumbnail
Circadian rhythm in pro-arrhythmic activity of pulmonary vein cardiomyocytes
Doctor L. Pannell (Bristol, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Basic science 1

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Low seroprevalence of neutralizing antibodies to adeno-associated virus serotype 9 in preparation for MyPEAK-1 study of TN-201 for individuals with MYBPC3-associated hypertrophic cardiomyopathy
thumbnail
Congress Presentation
NAN-CS101: A first-in-human Phase 1 open-label dose-escalation study of AB-1002 gene therapy for the treatment of NYHA class III heart failure
thumbnail
Congress Presentation
AAV-mediated gene therapy improves cardiac function in humanized PLN-R14del mice: a preclinical model of PLN-R14del induced cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources